Abstract

BackgroundThe discovery of robust and trans-ethnically replicated DNA methylation markers of metabolic phenotypes, has hinted at a potential role of epigenetic mechanisms in lipid metabolism. However, DNA methylation and the lipid compositions and lipid concentrations of lipoprotein sizes have been scarcely studied. Here, we present an epigenome-wide association study (EWAS) (N = 5414 total) of mostly lipid-related metabolic measures, including a fine profiling of lipoproteins. As lipoproteins are the main players in the different stages of lipid metabolism, examination of epigenetic markers of detailed lipoprotein features might improve the diagnosis, prognosis, and treatment of metabolic disturbances.ResultsWe conducted an EWAS of leukocyte DNA methylation and 226 metabolic measurements determined by nuclear magnetic resonance spectroscopy in the population-based KORA F4 study (N = 1662) and replicated the results in the LOLIPOP, NFBC1966, and YFS cohorts (N = 3752). Follow-up analyses in the discovery cohort included investigations into gene transcripts, metabolic-measure ratios for pathway analysis, and disease endpoints. We identified 161 associations (p value < 4.7 × 10−10), covering 16 CpG sites at 11 loci and 57 metabolic measures. Identified metabolic measures were primarily medium and small lipoproteins, and fatty acids. For apolipoprotein B-containing lipoproteins, the associations mainly involved triglyceride composition and concentrations of cholesterol esters, triglycerides, free cholesterol, and phospholipids. All associations for HDL lipoproteins involved triglyceride measures only. Associated metabolic measure ratios, proxies of enzymatic activity, highlight amino acid, glucose, and lipid pathways as being potentially epigenetically implicated. Five CpG sites in four genes were associated with differential expression of transcripts in blood or adipose tissue. CpG sites in ABCG1 and PHGDH showed associations with metabolic measures, gene transcription, and metabolic measure ratios and were additionally linked to obesity or previous myocardial infarction, extending previously reported observations.ConclusionOur study provides evidence of a link between DNA methylation and the lipid compositions and lipid concentrations of different lipoprotein size subclasses, thus offering in-depth insights into well-known associations of DNA methylation with total serum lipids. The results support detailed profiling of lipid metabolism to improve the molecular understanding of dyslipidemia and related disease mechanisms.

Highlights

  • The discovery of robust and trans-ethnically replicated Deoxyribonucleic acid (DNA) methylation markers of metabolic pheno‐ types, has hinted at a potential role of epigenetic mechanisms in lipid metabolism

  • DNA methylation is linked to a variety of metabolic pathways As a further approach to link enzymatic activity of selected metabolic pathways with CpG sites showing replicated associations, we examined 60 ratios of metabolic measures closely related to enzymatic substrates or products, or ratios linked to metabolic diseases in the discovery cohort (Additional file 4: Supplemental Results and Methods: Associations with metabolic ratios from additional pathways, Additional file 14: Table S10)

  • Results related to ApoB lipoproteins, particles involved in the endogenous lipoprotein pathway, suggest that DNA methylation is intertwined with the changes in lipid compositions and concentrations that all sizes of

Read more

Summary

Introduction

The discovery of robust and trans-ethnically replicated DNA methylation markers of metabolic pheno‐ types, has hinted at a potential role of epigenetic mechanisms in lipid metabolism. Dyslipidemia refers to abnormal levels of one or more lipids, such as plasma cholesterol, high-density lipoprotein cholesterol (HDL), low-density lipoprotein cholesterol (LDL), and/or plasma triglycerides (TG) in blood, leading to complex cardiometabolic diseases such as atherosclerosis, type 2 diabetes (T2D), or myocardial infarction (MI) [1,2,3,4,5]. Due to their poor solubility in blood, lipids are transported in lipoprotein particles that can be categorized according to their size, density, and composition as shown in Fig. 1 [6,7,8]. Omega-3 to omega-6 FAs ratios and branched chain amino acids, such as isoleucine, are associated with metabolic outcomes [11,12,13]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call